We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience.
By continuing to use our site, you agree to the use of cookies. Learn more about cookies here.

X

ESCMID: Updates to C. difficile Diagnostic Guidelines

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) has recently released new guidelines on best practice methods to diagnose Clostridium difficile infection (CDI). The latest document updates the original 2009 guidelines and includes recommendations concerning the use of new diagnostic technology such as nucleic acid amplification tests (NAAT). The study that underpins the new guidelines was initiated in June 2014.

Read more on guidelines: C. difficile infection (CDI) and updates to the guidelines

Reference: ESCMID Updates C. difficile Diagnostic Guidelines. 24.8.2016. http://www.infectioncontroltoday.com/news/2016/08/escmid-updates-c-difficile-diagnostic-guidelines.aspx

--

Orion GenRead®

Molecular btesting for healthier life

Orion Diagnostica’s C. difficile test, Orion GenRead C. difficile was launched in the spring 2015. Orion GenRead is a flexible benchtop solution including a small instrument and ready to use kits. It is intended for rapid detection of pathogens, offering a fast, affordable and accurate alternative for nucleic acid testing in various laboratory settings.

Orion GenRead is based on Orion Diagnostica’s proprietary isothermal nucleic acid amplification technology, SIBA® (Strand Invasion Based Amplification).

Orion GenRead C. difficile test is available.

SIBA®

SIBA (Strand Invasion Based Amplification) is Orion Diagnostica’s proprietary isothermal nucleic acid amplification technology. The technology is based on amplification of nucleic acids at a constant temperature of 40 degrees Celsius.

Read more:

SIBA

Orion GenRead C. difficile

Orion_GenRead_C_Diff_Kit_and_Instrument_web_72res